To date, the mechanisms responsible for the impact of antidepressants on the CXCL12–CXCR4 brain axis have not been studied in any animal model of depression, so further understanding of the fluoxetine signaling pathways downstream of CXCR4 will be crucial. The gene discussed is CXCL12; the disease is major depressive disorder.